{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:22:02Z","timestamp":1793863322078,"version":"4.6.1"},"reference-count":98,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Osteoporosis is defined as a condition of increased risk of fracture due to decreased bone strength. In developed countries, the number of patients with osteoporosis and fragility fractures has been increasing in recent years due to the growing elderly population, posing a social challenge not only to fracture patients and their families but also to the social healthcare economy. Osteoporosis can be divided into two categories: primary osteoporosis caused by aging or menopause and secondary osteoporosis caused by metabolic or inflammatory diseases or drugs such as glucocorticoids. The majority of patients have primary osteoporosis, and the pathogenesis of postmenopausal osteoporosis and factors associated with fragility fractures in the elderly have been elucidated. On the other hand, rheumatoid arthritis (RA) is one of the causes of secondary osteoporosis. RA is a chronic inflammatory disease characterized by joint swelling and destruction. Most often, treatment focuses on suppressing these symptoms. However, physicians should be aware of the risk of osteoporosis in RA patients, because (1) RA is a chronic inflammatory disease, which itself can be a risk factor for osteoporosis; (2) glucocorticoids, which are sometimes administered to treat RA, can be a risk factor for osteoporosis; and (3) patients with RA are becoming older, and aging is an osteoporosis risk factor. A comprehensive understanding of the pathogenesis of osteoporosis and its fragility fractures requires elucidating the mechanisms underlying osteoclast activation, which drives their development. Furthermore, identifying the factors associated with fragility fractures is essential. This review summarizes the pathogenesis of osteoporosis, the factors associated with fragility fractures, and the associations between RA and osteoporosis development.<\/jats:p>","DOI":"10.3390\/jcm14041138","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T04:44:03Z","timestamp":1739162643000},"page":"1138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Osteoporosis and Rheumatoid Arthritis: Mechanisms Underlying Osteoclast Differentiation and Activation or Factors Associated with Hip Fractures"],"prefix":"10.3390","volume":"14","author":[{"given":"Takeshi","family":"Miyamoto","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00774-022-01352-4","article-title":"Trends in osteoporosis prevalence over a 10-year period in Japan: The ROAD study 2005\u20132015","volume":"40","author":"Yoshimura","year":"2022","journal-title":"J. Bone Miner. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00774-009-0080-8","article-title":"Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: The research on osteoarthritis\/osteoporosis against disability study","volume":"27","author":"Yoshimura","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid Arthritis\u2014Common Origins, Divergent Mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41584-024-01120-w","article-title":"Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases","volume":"20","author":"Buttgereit","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_5","unstructured":"World Health Organization (2004). WHO scientific group on the assessment of osteoporosis at primary health care level. Summary Meeting Report, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00198-024-07311-1","article-title":"First fracture in rheumatoid arthritis: Analysis by fracture site, gender, age, and comorbidities","volume":"36","author":"Keen","year":"2025","journal-title":"Osteoporos. Int."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wu, D., Luo, Y., Li, T., Zhao, X., Lv, T., Fang, G., Ou, P., Li, H., Luo, X., and Huang, A. (2022). Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1051082"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/mr\/roab130","article-title":"Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis","volume":"32","author":"Furuya","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.1308755110","article-title":"HIF1\u03b1 is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis","volume":"110","author":"Miyauchi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","article-title":"Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20050645","article-title":"DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells","volume":"202","author":"Yagi","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/nm1514","article-title":"v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation","volume":"12","author":"Lee","year":"2006","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1073\/pnas.0702811104","article-title":"CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts","volume":"104","author":"Cui","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/jbmr.1575","article-title":"Osteoclast stimulatory transmembrane protein and dendritic cell\u2013specific transmembrane protein cooperatively modulate cell\u2013cell fusion to form osteoclasts and foreign body giant cells","volume":"27","author":"Miyamoto","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1359\/jbmr.070401","article-title":"Induction of DC-STAMP by alternative activation and downstream signaling mechanisms","volume":"22","author":"Yagi","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm.2007","article-title":"Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis","volume":"15","author":"Zhao","year":"2009","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2006-09-048249","article-title":"MafB negatively regulates RANKL-mediated osteoclast differentiation","volume":"109","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20091957","article-title":"The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis","volume":"207","author":"Miyauchi","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1073\/pnas.0912779107","article-title":"Blimp1-mediated repression of negative regulators is required for osteoclast differentiation","volume":"107","author":"Nishikawa","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"28508","DOI":"10.1074\/jbc.M112.356634","article-title":"Conditional inactivation of Blimp1 in adult mice promotes increased bone mass","volume":"287","author":"Miyauchi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.exphem.2010.06.002","article-title":"Slow-cycling\/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen","volume":"38","author":"Guitart","year":"2010","journal-title":"Exp. Hematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2016.01.033","article-title":"Hif1\u03b1 is required for osteoclast activation and bone loss in male osteoporosis","volume":"470","author":"Tando","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sato, Y., Miyauchi, Y., Yoshida, S., Morita, M., Kobayashi, T., Kanagawa, H., Katsuyama, E., Fujie, A., Hao, W., and Tando, T. (2014). The Vitamin D Analogue ED71 but Not 1,25(OH)2D3 Targets HIF1\u03b1 Protein in Osteoclasts. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111845"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Morita, M., Sato, Y., Iwasaki, R., Kobayashi, T., Watanabe, R., Oike, T., Miyamoto, K., Toyama, Y., Matsumoto, M., and Nakamura, M. (2016). Selective Estrogen Receptor Modulators Suppress Hif1\u03b1 Protein Accumulation in Mouse Osteoclasts. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165922"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbrc.2016.12.053","article-title":"Selective estrogen receptor modulators and the vitamin D analogue eldecalcitol block bone loss in male osteoporosis","volume":"482","author":"Sato","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Shinohara","year":"2011","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm.3668","article-title":"PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1359\/jbmr.080511","article-title":"Bisphosphonate-induced osteopetrosis: Novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases","volume":"23","author":"Whyte","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/JBJS.K.01181","article-title":"Bisphosphonates and nonhealing femoral fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: A systematic review from the Research on Adverse Drug Events And Reports (RADAR) project","volume":"95","author":"Edwards","year":"2013","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","article-title":"Severely suppressed bone turnover and atypical skeletal fragility","volume":"93","author":"Visekruna","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","article-title":"Osteoprotection by semaphorin 3A","volume":"485","author":"Hayashi","year":"2012","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","article-title":"Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency","volume":"273","author":"Gelb","year":"1996","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1101\/gad.1119303","article-title":"Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation","volume":"17","author":"Kim","year":"2003","journal-title":"Genes Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2015.01.012","article-title":"Bcl6 promotes osteoblastogenesis through Stat1 inhibition","volume":"457","author":"Fujie","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e10211","DOI":"10.1002\/jbm4.10211","article-title":"The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women with Osteoporosis: Results From the FRAME Study","volume":"3","author":"Geusens","year":"2019","journal-title":"JBMR Plus"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"ACTIVE Study Investigators. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"116865","DOI":"10.1016\/j.bone.2023.116865","article-title":"A machine learning-based scoring system and ten factors associated with hip fracture occurrence in the elderly","volume":"176","author":"Uragami","year":"2023","journal-title":"Bone"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1035999100","article-title":"IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist","volume":"100","author":"Nakae","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.42642","article-title":"Synovial Tissue Heterogeneity in Japanese Patients With Rheumatoid Arthritis Elucidated Using a Cell-Type Deconvolution Approach","volume":"75","author":"Nakajima","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-022-01213-w","article-title":"Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis","volume":"54","author":"Ishigaki","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2006.051979","article-title":"Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"65","author":"Cutolo","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1\u03b2 and TNF\u03b1-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2443.1999.00265.x","article-title":"Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice","volume":"4","author":"Naito","year":"1999","journal-title":"Genes Cells"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00774-017-0890-z","article-title":"Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions","volume":"36","author":"Oya","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41590-019-0526-7","article-title":"Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1","volume":"20","author":"Hasegawa","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1074\/jbc.M114.568360","article-title":"Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells","volume":"290","author":"Katsuyama","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Oike, T., Sato, Y., Kobayashi, T., Miyamoto, K., Nakamura, S., Kaneko, Y., Kobayashi, S., Harato, K., Saya, H., and Matsumoto, M. (2017). Stat3 as a potential therapeutic target for rheumatoid arthritis. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-11233-w"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40520-023-02432-9","article-title":"Chronic arthritides and bone structure: Focus on rheumatoid arthritis-an update","volume":"35","author":"Messina","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2018-214894","article-title":"Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis","volume":"78","author":"Finzel","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00774-015-0702-2","article-title":"Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors","volume":"34","author":"Kanagawa","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/jbmr.3754","article-title":"CTLA4-Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages","volume":"34","author":"Okada","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00774-024-01502-w","article-title":"The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis","volume":"42","author":"Tanaka","year":"2024","journal-title":"J. Bone Miner. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Leufkens","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11657-018-0424-x","article-title":"Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: A population-based case-control study","volume":"13","author":"Amiche","year":"2018","journal-title":"Arch. Osteoporos."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00774-022-01325-7","article-title":"Fracture risk associated with glucocorticoid-induced osteoporosis in Japan","volume":"40","author":"Soen","year":"2022","journal-title":"J. Bone Miner. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/1756-185X.13974","article-title":"Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan","volume":"23","author":"Nakajima","year":"2020","journal-title":"Int. J Rheum. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00198-016-3823-0","article-title":"Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys","volume":"28","author":"Yoshimura","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Miyamoto, K., Hirayama, A., Sato, Y., Ikeda, S., Maruyama, M., Soga, T., Tomita, M., Nakamura, M., Matsumoto, M., and Yoshimura, N. (2021). A Metabolomic Profile Predictive of New Osteoporosis or Sarcopenia Development. Metabolites, 11.","DOI":"10.3390\/metabo11050278"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"116570","DOI":"10.1016\/j.bone.2022.116570","article-title":"Osteoporosis and sarcopenia are associated with each other and reduced IGF1 levels are a risk for both diseases in the very old elderly","volume":"166","author":"Hata","year":"2023","journal-title":"Bone"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-023-00921-9","article-title":"Rheumatoid sarcopenia: Loss of skeletal muscle strength and mass in rheumatoid arthritis","volume":"19","author":"Bennett","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"116416","DOI":"10.1016\/j.bone.2022.116416","article-title":"Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study","volume":"160","author":"Chiba","year":"2022","journal-title":"Bone"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.semarthrit.2018.05.001","article-title":"Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study","volume":"48","author":"Yue","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Figueiredo, C.P., Perez, M.O., Sales, L.P., Medeiros, A.C., Caparbo, V.F., and Pereira, R.M.R. (2021). Bone erosion in the 2nd metacarpophalangeal head: Association with its bone mineral density by HR-pQCT in rheumatoid arthritis patients. BMC Musculoskelet. Disord., 22.","DOI":"10.1186\/s12891-021-03992-5"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1356","DOI":"10.1002\/jsp2.1356","article-title":"The potential effect of romosozumab on perioperative management for instrumentation surgery","volume":"7","author":"Ishikawa","year":"2024","journal-title":"JOR Spine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"115786","DOI":"10.1016\/j.bone.2020.115786","article-title":"Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context","volume":"143","author":"Cortet","year":"2021","journal-title":"Bone"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:30:21Z","timestamp":1760027421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":98,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14041138"],"URL":"https:\/\/doi.org\/10.3390\/jcm14041138","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}